---
figid: PMC10758146__ijmsv21p0284g001
figtitle: Lithium exerts neuroprotective effects in ischemic stroke through multiple
  mechanisms
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10758146
filename: PMC10758146__ijmsv21p0284g001.jpg
figlink: /pmc/articles/PMC10758146/figure/F1
number: F1
caption: 'Lithium exerts neuroprotective effects in ischemic stroke through multiple
  mechanisms. GSK-3: glycogen synthase kinase 3; mTOR: mammalian target of rapamycin;
  MAPK: mitogen-activated protein kinase; ERK: extracellular signal- regulated kinase;
  MMP: matrix metalloproteinase; NMDAR: N-methyl-d-aspartate receptor; FoxO3a: forkhead
  box O3; NLRP3: nucleotide-binding oligomerization domain, leucine-rich repeat and
  pyrin domain-containing protein 3; cAMP: cyclic adenosine monophosphate; PKA: protein
  kinase A; PI3K: phosphatidylinositol 3-kinase; AKT: protein kinase B; CREB: cAMP-response
  element binding protein; BDNF: brain-derived neurotrophic factor; Trk: tropomyosin-related
  kinase; PSD-95: postsynaptic density protein 95; GAP-43: growth associated protein-43;
  BBB: blood-brain barrier. Lines with solid arrows represent stimulatory connections;
  lines with flattened ends represent inhibitory connections. Dashed lines represent
  pathways with reduced activity as a result of lithium treatment'
papertitle: 'Exploring the Neuroprotective Effects of Lithium in Ischemic Stroke:
  A literature review'
reftext: Weihua Wang, et al. Int J Med Sci. 2024;21(2).
year: '2024'
doi: 10.7150/ijms.88195
journal_title: International Journal of Medical Sciences
journal_nlm_ta: Int J Med Sci
publisher_name: Ivyspring International Publisher
keywords: Ischemic stroke | Neuroprotection | Lithium | Molecular mechanism | Mitochondrial
  dysfunction | Inflammatory marker
automl_pathway: 0.8857765
figid_alias: PMC10758146__F1
figtype: Figure
redirect_from: /figures/PMC10758146__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10758146__ijmsv21p0284g001.html
  '@type': Dataset
  description: 'Lithium exerts neuroprotective effects in ischemic stroke through
    multiple mechanisms. GSK-3: glycogen synthase kinase 3; mTOR: mammalian target
    of rapamycin; MAPK: mitogen-activated protein kinase; ERK: extracellular signal-
    regulated kinase; MMP: matrix metalloproteinase; NMDAR: N-methyl-d-aspartate receptor;
    FoxO3a: forkhead box O3; NLRP3: nucleotide-binding oligomerization domain, leucine-rich
    repeat and pyrin domain-containing protein 3; cAMP: cyclic adenosine monophosphate;
    PKA: protein kinase A; PI3K: phosphatidylinositol 3-kinase; AKT: protein kinase
    B; CREB: cAMP-response element binding protein; BDNF: brain-derived neurotrophic
    factor; Trk: tropomyosin-related kinase; PSD-95: postsynaptic density protein
    95; GAP-43: growth associated protein-43; BBB: blood-brain barrier. Lines with
    solid arrows represent stimulatory connections; lines with flattened ends represent
    inhibitory connections. Dashed lines represent pathways with reduced activity
    as a result of lithium treatment'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CTNNB1
  - NLRP3
  - NTRK2
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - FOXO3
  - GSK3A
  - GSK3B
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - AKT1
  - AKT2
  - AKT3
  - BDNF
  - BDNF-AS
  - GRIN1
  - GRIN2A
  - GRIN2B
  - GRIN2C
  - GRIN2D
  - GRIN3A
  - GRIN3B
  - MTOR
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - EPHB2
  - DLG4
  - GAP43
  - MMP9
  - CAMP
  - Ca2+
  - lithium
---
